ArticleActa biochimica et biophysica Sinica2024

CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway.

Yunlian Diao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.